Presentation is loading. Please wait.

Presentation is loading. Please wait.

Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  Masami Sato, MDa, b, Teruaki Koike, MDa,

Published byYolanda Franco Modified over 5 years ago

Similar presentations

Presentation on theme: "Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  Masami Sato, MDa, b, Teruaki Koike, MDa,"— Presentation transcript:

1 Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  Masami Sato, MDa, b, Teruaki Koike, MDa, Kohei Yokoi, MDa, Hirohito Tada, MDa, Motoyasu Sagawa, MDa, b, Akira Sakurada, MDb, Tatsuo Tanita, MDb, Takashi Kondo, MDa, b, Shigefumi Fujimura, MDa, b, Ryosuke Tsuchiya, MDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 119, Issue 6, Pages (June 2000) DOI: /mtc Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Survival curves after the first operation. There was no significant difference (P = .46, log rank test). The 95% confidence limits at 5 years in the group with complete resection were 0 to 0.88. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Survival curves after upper mediastinal dissection according to the length of time from the first operation to recurrence in patients undergoing complete resection. There was no significant difference between groups (P = .36, log rank test). The 95% confidence limits at 4 years in group labeled “more than 2 years” were 0.1 to 1.2. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  Masami Sato, MDa, b, Teruaki Koike, MDa,"

Similar presentations

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer  Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.
Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer  Mitsunori Ohta, MDa, Noriyoshi Sawabata, MDb, Hajime.

Efficacy and safety of tracheobronchoplasty after induction therapy for locally advanced lung cancer  Mitsunori Ohta, MDa, Noriyoshi Sawabata, MDb, Hajime.
A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.

A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique  Masahiko Higashiyama, MDa, Ken.
Congenital bronchial cyst with recurrent submassive hemoptysis

Congenital bronchial cyst with recurrent submassive hemoptysis
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,

Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,
Ultrasound, endoscopy, and the recurrent nerve

Ultrasound, endoscopy, and the recurrent nerve
Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer  Takeshi Funatsu, MD, Yoshito.

Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer  Takeshi Funatsu, MD, Yoshito.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,
Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection*  T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.

Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection*  T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.
Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases  Toshihiko Sato, MD,

Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases  Toshihiko Sato, MD,
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Similar presentations

Ads by Google